Yale University · Biomedical EngineeringDe Feyter Imaging Lab
Henk De Feyter · New Haven, Connecticut
Research Focus
Dr. Henk De Feyter's lab at Yale University focuses on advancing brain tumor imaging techniques, particularly for glioblastoma, which is a common and aggressive type of brain cancer. They are innovating a new MRI-based method called Deuterium Metabolic Imaging (DMI) to detect abnormal glucose metabolism in brain tumors, providing a non-invasive way to monitor tumor progression and treatment response. This research aims to improve diagnosis and treatment strategies for patients with brain tumors by offering a more reliable imaging option compared to traditional methods.
glioblastomaDeuterium Metabolic ImagingMRIbrain tumorstumor metabolism
Research Aims
3AIM 01Validate the DMI technique for detecting abnormal glucose metabolism in glioblastoma.
AIM 02Compare DMI performance with existing imaging methods.
AIM 03Establish DMI's ability to monitor treatment response in patients.
Skills the Lab Values
magnetic resonance imaging (MRI)deuterium metabolic imaging (DMI)metabolic imaging techniqueshistopathologyclinical trial design
Output against the department
Publications68bottom 9% of dept.541st of 595
this lab
most publishedleast published
Citations3.4kbottom 26% of dept.439th of 595
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.